why choose us

First received: July 12, 2022

Clinical Trial: Using Radiomics to Predict Neoadjuvant Chemotherapy Efficacy

Study Status: Completed

Recruit Status: Completed

Condition: Gastric Cancer

Study Type: Observational [Patient Registry]


Official Title: Using Radiomics to Predict Neoadjuvant Chemotherapy Efficacy and Postoperative Adjuvant Chemotherapy Benefit in Advanced Gastric Cancer: a Two-center Study

Brief Summary: Neoadjuvant chemotherapy (NC) is an important treatment for advanced gastric cancer (AGC). However, tools that effectively predict the efficacy of NC before treatment are lacking. Computed tomography images before and after NC were used to construct a deep learning-based radiomics signature to predict the efficacy of NC, prognoses and postoperative adjuvant chemotherapy benefit.

Read more